Standalone Audited Financial Results for the quarter and financial year ended 315t March 2025. In this regard, please find the enclosed copies of the following: (i) Statement showing ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
The board, at its meeting on 28th May 2025, approved the standalone audited financial results for Q4 and FY ended 31 March 2025. FY25 total income fell sharply to ₹879.30 lakhs from ₹1,982.24 lakhs in FY24, a decline of roughly 56%, driven mainly by lower production revenue. Despite the revenue drop, FY25 net profit rose to ₹400.02 lakhs (vs ₹374.47 lakhs in FY24), helped by ₹504.90 lakhs of other income and depreciation adjustments. Q4 FY25 alone posted a loss of ₹29.31 lakhs, hit by a negative ₹2,200 lakh entry in the Exhibition segment after film production rights sold earlier were returned by the client (linked to an arbitration award). The auditor (Vivekanandan Associates) issued an unmodified opinion. The board also appointed Ms. N. Srividhya as Secretarial Auditor for 5 years from FY26. The balance sheet shows deeply negative other equity of (₹4,553.24 lakhs) and total equity of (₹3,081.24 lakhs), with non-current borrowings of ₹3,582.95 lakhs, leaving the company with negative net worth.
Shareholders should note the sharp revenue contraction in FY25 and the negative net worth, which points to balance sheet stress even though FY25 PAT improved on the back of one-time other income. The negative operating cash flow of (₹836.23 lakhs) and Q4 loss highlight ongoing operational challenges, which could weigh on the stock and raise going-concern questions despite the clean audit opinion.